ABT-670

ABT-670 is a drug which acts as a potent, orally bioavailable dopamine agonist selective for the D₄ subtype, which was developed as a possible treatment for erectile dysfunction,^[1] although its current uses are limited to scientific research.^[2]

ABT-670

Identifiers
IUPAC name 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide
CAS Number	630119-43-6 N
PubChem CID	16094676
ChemSpider	17252978 Y
UNII	4L6071XH2J
ChEMBL	ChEMBL219182 Y
CompTox Dashboard (EPA)	DTXSID30212235
Chemical and physical data
Formula	C19H23N3O2
Molar mass	325.412 g·mol−1
3D model (JSmol)	Interactive image
SMILES [O-][n+]1ccccc1C(CC3)CCN3CNC(=O)c(c2)cccc2C
InChI InChI=1S/C19H23N3O2/c1-15-5-4-6-17(13-15)19(23)20-14-21-11-8-16(9-12-21)18-7-2-3-10-22(18)24/h2-7,10,13,16H,8-9,11-12,14H2,1H3,(H,20,23) Y Key:PUMMPCXNEPHBNN-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

See also

• ABT-724
• Bremelanotide
• Cabergoline
• Flibanserin
• Intrinsa
• Melanotan II
• Pramipexole
• PF-219,061
• Tibolone
• UK-414,495